期刊文献+

胃酸分泌调节肽和KA8肽的生物活性研究 被引量:1

Effects of Oxyntomodulin and KA8 Peptide on Gastric Acid Secretion and Blood Sugar Concentration
下载PDF
导出
摘要 分别中枢和外周给以胃酸分泌调节肽(OM)及其C端8肽KA8肽,观察并比较它们对胃酸分泌、血糖及其调节激素的影响.结果表明,外周给以KA8肽可抑制胃酸分泌,而脑室给以KA8肽和OM对胃酸分泌无影响,外周给以KA8肽和OM对血糖调节激素无影响,中枢给以OM具升高血糖的作用。 Oxyntomodulin (OM) consists of glucagon and KA8 peptide. We have demonstrated that KA8 peptide administrated by intravenous infusion could inhibite the secretion of gastric acid.Now OM and KA8 peptide were given by iv infusion or icv to rats to observe the effects on blood sugar regulation and the secretion of gastric acid. As compared with control group, we found that 1. Neither iv OM nor iv KA8 peptide had no effect on the concentration of blood sugar, insulin and glucagon. 2. The raise of blood sugar and decline of insulin concentration were observed when OM but not KA8 peptide given by icv(lug). 3. No effect was found on the secretion of gastric acid offten when OM and KA8 peptide was given via icv. Based on these results, we conclude that KA8 had the effect on the secretion of gastric acid with peripheral administration. While no effect was observed with KA8 and OM given into cerebral ventricles. There was no effect on blood sugar regulating hormone with KA8 and OM administered peripheraly, while OM may elevate the blood sugar when given into cerebral ventricles.
出处 《首都医学院学报》 1994年第1期34-37,共4页
关键词 胃酸分泌 调节肽 KA8肽 胃酸 oxytomedulin KA8 gastric acid blood sugar
  • 相关文献

参考文献2

共引文献3

同被引文献20

  • 1李非,张雁,张淑文,孙家邦.胃酸调节肽C端8肽对胰腺炎大鼠胰腺外分泌的影响[J].中华实验外科杂志,2006,23(1):41-42. 被引量:2
  • 2Bataille D, Tatemoto K, Gespach C, et al. Isolation of glucagon-37(bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide[J]. FEBS Lett, 1973, 146, 79-86.
  • 3Bonnet C, Martinez, C, Jarrousse A, et al. H-Lys-Arg-Asn- Lys-Asn-Asn-OH is the minimal active structure of oxyntomodulin[J]. Elsevier Science Inc,1995, 17(3): 557-561.
  • 4Bell G I,Sanchez-Pescador R, Laybourn P J, et al. Exon duplication and divergence in the human preproglucagon gene[J]. Nature, 1983, 304, 368-371.
  • 5Lopez L C, Frazicr M L, Su C J, et al. Mammalian preproglucagon contains three glucagon related peptides[J]. Proc Natl Acad Sci USA, 1983, 80 :5485-5489.
  • 6Audousset-Puech M P, Dufour M, Kervran A, et al. Solidphase peptide synthesis of human (Nle-27)-oxyntomodulin. preliminary evaluation of its biological activities [J]. FEBS Lett,1986, 200:181-185.
  • 7Dakin C L, Small C J, Park A J, et al. Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rata[J]. Am J Physiol Endocrinol Metab,2002, 283, 1173-1177.
  • 8Cohen M A, Ellis S M, Le Roux C W, et al. Oxyntomodulin suppresses appetite and reduces food intake in humans[J]. J Clin Endocrinol Metab, 2003, 88: 4696-4701.
  • 9Dakin C L,Small C J, Batterham R L, et al. Peripheral oxyntomodulin reduces food intake and body weight gain in rats[J].Endocrinology,2004, 145: 2687-2695.
  • 10Wynne K,Park A J, Small C J, et al. Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects, a double blind, randomized, controlled trial[J]. Diabetes,2005, 54(8): 2390-2395.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部